Could the Fight Against Treatment Failures in Giardiasis Lead to a Second Childhood for Quinacrine?

dc.contributor.authorÁngel A. Escobedo
dc.contributor.authorPedro Almirall
dc.contributor.authorAlfonso J. Rodríguez‐Morales
dc.contributor.authorEsperanza Duquesne-Rivero
dc.contributor.authorRoberto Suarez-Mella
dc.contributor.authorEduardo Ruiz-Blanco
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:15:57Z
dc.date.available2026-03-22T21:15:57Z
dc.date.issued2017
dc.descriptionCitaciones: 1
dc.identifier.doi10.1093/infdis/jix375
dc.identifier.urihttps://doi.org/10.1093/infdis/jix375
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/86912
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofThe Journal of Infectious Diseases
dc.sourceBritish Society for Antimicrobial Chemotherapy
dc.subjectMedicine
dc.subjectVirology
dc.subjectLead poisoning
dc.subjectImmunology
dc.subjectIntensive care medicine
dc.titleCould the Fight Against Treatment Failures in Giardiasis Lead to a Second Childhood for Quinacrine?
dc.typeletter

Files